Investing_saints
02/07/25 22:53
Ha respondido al tema
Farmas USA
XBI Leerink:" Biopharma Cash Runway Map: Bottom Line: Amid significant macroeconomic challenges for theBiopharma sector, we update our cash runway map for "not-yetprofitable"companies across the Leerink Partners' BiopharmaCoverage Universe. The map highlightsvalue (with >2 years cash runway, trading below cash) and growthstocks (with >2 years of cash runway, trading above cash), as well ashigh-volatility catalyst plays (<2 years of cash runway, trading abovecash) and stocks with near-term financial overhangs (<2 years cashrunway, trading below cash), within each sub-sector.● Across our Biopharma coverage universe, as of June 2025, ~51%of currently unprofitable covered companies had >2 years of cashrunway, up from 40% in June 2023...."https://x.com/TomSilver39/status/1940115999912862075?t=fVTZVhezyu6aipIJZwqenA&s=19